Cargando…

Case Report: Multiple Sclerosis Relapses After Vaccination Against SARS-CoV2: A Series of Clinical Cases

Objective: To describe a temporal association between COVID-19 vaccine administration and multiple sclerosis (MS) relapses. Methods: This case series study was collected in four MS Centres in Central Italy, using data from 16 MS patients who received COVID-19 vaccination and presented both clinicall...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nistri, Riccardo, Barbuti, Elena, Rinaldi, Virginia, Tufano, Laura, Pozzilli, Valeria, Ianniello, Antonio, Marinelli, Fabiana, De Luca, Giovanna, Prosperini, Luca, Tomassini, Valentina, Pozzilli, Carlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569136/ https://www.ncbi.nlm.nih.gov/pubmed/34744992 http://dx.doi.org/10.3389/fneur.2021.765954

Ejemplares similares

Should we treat pediatric radiologically isolated syndrome? An 18-year follow-up case report
por: Barbuti, Elena, et al.
Publicado: (2023)

Predicting the profile of increasing disability in multiple sclerosis
por: Tomassini, Valentina, et al.
Publicado: (2018)

The Clinical Relevance of Force Platform Measures in Multiple Sclerosis: A Review
por: Prosperini, Luca, et al.
Publicado: (2013)

Dalfampridine improves slowed processing speed in multiple sclerosis patients with mild motor disability: post hoc analysis of a randomized controlled trial
por: Pozzilli, Carlo, et al.
Publicado: (2021)

A Comprehensive Approach to Disentangle the Effect of Cerebellar Damage on Physical Disability in Multiple Sclerosis
por: Ruggieri, Serena, et al.
Publicado: (2020)

Management of breakthrough disease in patients with multiple sclerosis: when an increasing of Interferon beta dose should be effective?
por: Prosperini, Luca, et al.
Publicado: (2011)

Similarities and differences between multiple sclerosis and type 1 diabetes
por: Pozzilli, Valeria, et al.
Publicado: (2021)

Oral Dalfampridine Improves Standing Balance Detected at Static Posturography in Multiple Sclerosis
por: Prosperini, Luca, et al.
Publicado: (2014)

CNS inflammatory demyelinating events after COVID-19 vaccines: A case series and systematic review
por: Rinaldi, Virginia, et al.
Publicado: (2022)

Prognostic Accuracy of NEDA-3 in Long-term Outcomes of Multiple Sclerosis
por: Prosperini, Luca, et al.
Publicado: (2021)

Eating Hubs in Multiple Sclerosis: Exploring the Relationship Between Mediterranean Diet and Disability Status in Italy
por: Felicetti, Federica, et al.
Publicado: (2022)

Oral contraceptives combined with interferon β in multiple sclerosis
por: Pozzilli, Carlo, et al.
Publicado: (2015)

Effectiveness of fingolimod in real-world relapsing-remitting multiple sclerosis Italian patients: the GENIUS study
por: Comi, Giancarlo, et al.
Publicado: (2020)

Relationship between Prolactin Plasma Levels and White Matter Volume in Women with Multiple Sclerosis
por: De Giglio, L., et al.
Publicado: (2015)

Assessing the Correlation between Grey and White Matter Damage with Motor and Cognitive Impairment in Multiple Sclerosis Patients
por: Sbardella, Emilia, et al.
Publicado: (2013)

Case Report: Exacerbation of Relapses Following mRNA COVID-19 Vaccination in Multiple Sclerosis: A Case Series
por: Quintanilla-Bordás, Carlos, et al.
Publicado: (2022)

Advances in spinal cord imaging in multiple sclerosis
por: Moccia, Marcello, et al.
Publicado: (2019)

The added value of spinal cord lesions to disability accrual in multiple sclerosis
por: Ruggieri, Serena, et al.
Publicado: (2023)

Advances in the treatment of relapsing—remitting multiple sclerosis — critical appraisal of fingolimod
por: Gasperini, Claudio, et al.
Publicado: (2013)

Neutralizing antibodies explain the poor clinical response to Interferon beta in a small proportion of patients with Multiple Sclerosis: a retrospective study
por: Sbardella, Emilia, et al.
Publicado: (2009)

Functional Connectivity Changes After Initial Treatment With Fingolimod in Multiple Sclerosis
por: Petsas, Nikolaos, et al.
Publicado: (2019)

Contribution of Metabolomics to Multiple Sclerosis Diagnosis, Prognosis and Treatment
por: Rispoli, Marianna Gabriella, et al.
Publicado: (2021)

Identifying responders and nonresponders to interferon therapy in multiple sclerosis
por: Prosperini, Luca, et al.
Publicado: (2014)

Case Report: Covid-19 in Multiple Sclerosis Patients Treated With Ocrelizumab: A Case Series
por: De Mercanti, Stefania F., et al.
Publicado: (2021)

No Changes in Functional Connectivity After Dimethyl Fumarate Treatment in Multiple Sclerosis
por: Piervincenzi, Claudia, et al.
Publicado: (2022)

Leg restlessness and hyperparathyroidism in Parkinson's disease, a further clue to RLS pathogenesis?
por: Marano, Massimo, et al.
Publicado: (2023)

Ponesimod in the Treatment of Relapsing Forms of Multiple Sclerosis: An Update on the Emerging Clinical Data
por: Ruggieri, Serena, et al.
Publicado: (2022)

A Rare Case of Susac's Syndrome Masquerading as Progressive-Relapsing Multiple Sclerosis
por: Darwish, Nedal, et al.
Publicado: (2022)

Potential Protective Role of Pregnancy and Breastfeeding in Delaying Onset Symptoms Related to Multiple Sclerosis
por: Logoteta, Alessandra, et al.
Publicado: (2023)

Severe Multiple Sclerosis Relapse After COVID-19 Vaccination: A Case Report
por: Maniscalco, Giorgia T., et al.
Publicado: (2021)

Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosis
por: Lucchini, Matteo, et al.
Publicado: (2021)

Are Neurophysiological Biomarkers Able to Discriminate Multiple Sclerosis Clinical Subtypes?
por: Belvisi, Daniele, et al.
Publicado: (2022)

Case Report: Baló's Concentric Sclerosis-Like Lesion in a Patient With Relapsing-Remitting Multiple Sclerosis Treated With Dimethyl Fumarate
por: Kania, Karolina, et al.
Publicado: (2022)

CADASIL vs. Multiple Sclerosis: Is It Misdiagnosis or Concomitant? A Case Series
por: Khan, Ayesha, et al.
Publicado: (2020)

Paediatric transverse myelitis during COVID-19 asymptomatic infection: A case report
por: Grasso, Eleonora, et al.
Publicado: (2021)

Evidence of Impaired Brain Activity Balance after Passive Sensorimotor Stimulation in Multiple Sclerosis
por: Petsas, Nikolaos, et al.
Publicado: (2013)

Investigating Serum sHLA-G Cooperation With MRI Activity and Disease-Modifying Treatment Outcome in Relapsing-Remitting Multiple Sclerosis
por: Amoriello, Roberta, et al.
Publicado: (2022)

Cost-effectiveness analysis of escalating to natalizumab or switching among immunomodulators in relapsing-remitting multiple sclerosis in Italy
por: Furneri, Gianluca, et al.
Publicado: (2019)

Humoral and Cellular Response to Spike of Delta SARS-CoV-2 Variant in Vaccinated Patients With Multiple Sclerosis
por: Petrone, Linda, et al.
Publicado: (2022)

Drug Holiday of Interferon Beta 1b in Multiple Sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority
por: Romano, Silvia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dh7ot5h67gkdnfg5t02ksruvrs